Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

NCT04066764 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Rivaroxaban
DRUG: Warfarin
DRUG: Nadroparin

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]